What are you
looking for?


Media Release Apr 18, 2024
Siegfried increases distribution to the shareholders and all proposals of the Board of Directors are approved
Ad hoc
Media Release Apr 02, 2024
Changes in Siegfried’s Management Team
Ad hoc
Media Release Feb 20, 2024
Siegfried continues to deliver profitable growth
Media Release Feb 02, 2024
Changes in Siegfried’s Senior Management Team
Media Release Dec 13, 2023
Siegfried confirmed in the Dow Jones Sustainability Index Europe for the third consecutive year
Ad hoc
Media Release Aug 17, 2023
Siegfried delivers strong sales growth and profitability in first half 2023
Media Release May 15, 2023
Changes in Siegfried’s Executive Committee
Ad hoc
Media Release May 04, 2023
Siegfried acquires majority stake in DINAMIQS to establish a best-in-class development and manufacturing organization for cell and gene therapies
Media Release Apr 25, 2023
Siegfried begins construction of a new global R&D Center for Drug Substances in Evionnaz
Media Release Apr 20, 2023
Siegfried increases distribution and ap­points new board member
Media Release Mar 09, 2023
Siegfried opens global Development Center for Drug Products in Barcelona
Ad hoc
Media Release Feb 22, 2023
On the move since 150 years: Siegfried significantly increases sales and profits in 2022


Let's get in touch

Peter Stierli
Head Corporate Communications
To top